Author

@CrweWorld CrweWorld

grade Ccorporatex.com/CrweWorld ↗

High-volume anonymous corporate-newsflow relay bot spanning the entire small-cap market

Auto-publishes terse, ticker-tagged one-line paraphrases of

trader score
·
hit rate
·
mean α
·
signals 14d
330

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Not yet in the scored-bets universe (fewer than 20 scoreable calls). Their last-14d mentions, direction-adjusted, have moved -5.6% since posting (mean over 101 mentions with price data).

Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-10-16RVLV@CrweWorld+0.00Announces that Revolve will report third-quarter 2026 results.·
2026-10-16CLPS@CrweWorld+0.00Reports fiscal results but provides no figures or direction versus estimates.·
2026-10-16LMT@CrweWorld+0.20Reports delivery of a C-130J-30 aircraft to the U.S. Navy for the TACAMO platform.+9.4%
2026-10-16CRIS@CrweWorld-0.35Reports pricing of an $8.5 million at-the-market private placement.·
2026-10-16GASXF@CrweWorld+0.15Reports well results and the spudding of another exploration well.·
2026-10-16GASX.CA@CrweWorld+0.15Reports well results and the spudding of another exploration well.·
2026-10-16GPUS@CrweWorld+0.25Reports completion and planned trading of tokens backed by 5,000 ounces of silver.+24.4%
2026-10-16NVDA@CrweWorld+0.20Reports a tenfold expansion of an Nvidia-associated Vietnamese agentic-AI dataset.-1.5%
2026-10-16ZTO@CrweWorld+0.00Announces that ZTO will report third-quarter 2026 results.·
2026-10-15NVDA@CrweWorld+0.15Reports LITEON showcasing power technology within Nvidia's MGX ecosystem.-2.9%
2026-10-15MENS@CrweWorld+0.15Jyong Biotech proposes a Texas facility supporting possible drug commercialization·
2026-10-15LUN.CA@CrweWorld+0.00Company provides Q3 2026 results call and webcast details·
2026-10-15LUN.CA@CrweWorld+0.00Company pre-announces unspecified items affecting Q3 results·
2026-10-15VOGX@CrweWorld+0.15Vogenx initiates a Phase 2b clinical study of mizagliflozin·
2026-10-15MVIS@CrweWorld+0.00MicroVision schedules its Q3 2026 financial-results announcement·

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.